(Q44573608)

4 December 2017

Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients (English)

1 reference

4 December 2017

0 references

Rita Moretti

1

1 reference

4 December 2017

Paola Torre

2

1 reference

4 December 2017

Rodolfo M Antonello

3

1 reference

4 December 2017

Giuseppe Cazzato

4

1 reference

4 December 2017

Stefania Griggio

5

1 reference

4 December 2017

Antonio Bava

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

American Journal of Alzheimer's Disease & Other Dementias

4 December 2017

1 reference

4 December 2017

18

1 reference

4 December 2017

4

1 reference

4 December 2017

205-214

1 reference

The spectrum of behavioral changes in Alzheimer's disease.

4 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

A metaanalysis of controlled trials of neuroleptic treatment in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

Olanzapine for psychosis in patients with Parkinson's disease with and without dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

CT in the differential diagnosis between Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

How common is dementia in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

Cerebral blood flow in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

Pharmacologic therapy for behavioral symptoms of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750301800410

10.1177/153331750301800410

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference